Literature DB >> 11595236

Identification and characterisation of Toxoplasma gondii protein farnesyltransferase.

M Ibrahim1, N Azzouz, P Gerold, R T Schwarz.   

Abstract

Prenylated proteins are involved in the regulation of DNA replication and cell cycling and have important roles in the regulation of cell proliferation. Protein farnesyltransferase and protein geranylgeranyltransferase are the two enzymes responsible for catalysing isoprene lipid modifications. Recently these enzymes have been targets for the development of cancer chemotherapeutics. Using metabolic labelling we identified isoprenylated proteins which suggests the presence of protein farnesyltransferase in Toxoplasma gondii. T. gondii protein farnesyltransferase is heat-labile and requires Mg(2+) and Zn(2+) ions for full activity. Peptidomimetic analogues as well as short synthetic peptides were tested in vitro as possible competitors for farnesyltransferase substrates. We found that the synthetic peptide (KTSCVIA) specifically inhibited T. gondiiprotein farnesyltransferase but not mammalian (HeLa cells) farnesyltransferase. Therefore this study suggests the possible development of specific inhibitors of T. gondiiprotein farnesyltransferase as an approach to parasitic protozoa therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595236     DOI: 10.1016/s0020-7519(01)00268-5

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  8 in total

1.  Isoprenoid metabolism in apicomplexan parasites.

Authors:  Leah Imlay; Audrey R Odom
Journal:  Curr Clin Microbiol Rep       Date:  2014-12-01

2.  In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum.

Authors:  Fabiana Morandi Jordão; Alexandre Yukio Saito; Danilo Ciccone Miguel; Valnice de Jesus Peres; Emília Akemi Kimura; Alejandro Miguel Katzin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

3.  Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Authors:  Anupama Tuladhar; Kathleen S Rein
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

4.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

Review 5.  Benzophenone: a ubiquitous scaffold in medicinal chemistry.

Authors:  Khemchand Surana; Bharatkumar Chaudhary; Monika Diwaker; Satyasheel Sharma
Journal:  Medchemcomm       Date:  2018-08-23       Impact factor: 3.597

Review 6.  Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.

Authors:  Isabelle Coppens
Journal:  Nat Rev Microbiol       Date:  2013-10-28       Impact factor: 60.633

7.  Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.

Authors:  Sethu C Nair; Carrie F Brooks; Christopher D Goodman; Angelika Sturm; Angelika Strurm; Geoffrey I McFadden; Sandeep Sundriyal; Justin L Anglin; Yongcheng Song; Silvia N J Moreno; Boris Striepen
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

8.  Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni.

Authors:  Alexandra Probst; Thi N Nguyen; Nelly El-Sakkary; Danielle Skinner; Brian M Suzuki; Frederick S Buckner; Michael H Gelb; Conor R Caffrey; Anjan Debnath
Journal:  Front Cell Infect Microbiol       Date:  2019-05-29       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.